Diabetes diagnosis and management among insured adults across metropolitan areas in the U.S

Autor: Eleonora Tan, Ritashree Chakrabarti, Timothy M. Dall, Wenya Yang, F. Ellen Loh, William Iacobucci, Erin Byrne
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Zdroj: Preventive Medicine Reports, Vol 10, Iss, Pp 227-233 (2018)
Preventive Medicine Reports
ISSN: 2211-3355
Popis: This study provides diabetes-related metrics for the 50 largest metropolitan areas in the U.S. in 2012—including prevalence of diagnosed and undiagnosed diabetes, insurance status of the population with diabetes, diabetes medication use, and prevalence of poorly controlled diabetes. Diabetes prevalence estimates were calculated using cross-sectional data combining the Behavioral Risk Factor Surveillance System, American Community Survey, National Nursing Home Survey, Census population files, and National Health and Nutrition Examination Survey. Analysis of medical claims files (2012 de-identified Normative Health Information database, 2011 Medicare Standard Analytical Files, and 2008 Medicaid Analytic eXtract) produced information on treatment and poorly controlled diabetes by geographic location, insurance type, sex, and age group. Among insured adults with diagnosed type 2 diabetes in 2012, the proportion receiving diabetes medications ranged from 83% in Oklahoma City, Oklahoma, to 65% in West Palm Beach, Florida. The proportion of treated patients with medical claims indicating poorly controlled diabetes was lowest in Minneapolis, Minnesota (36%) and highest in Texas metropolitan areas of Austin (51%), San Antonio (51%), and Houston (50%). Estimates of diabetes detection and management across metropolitan areas often differ from state and national estimates. Local metrics of diabetes management can be helpful for tracking improvements in communities over time.
Highlights • Key diabetes metrics vary by MSA and differ substantially from the national averages. • New York City had 1.2 million adults with diabetes; Southern New Jersey had 50,200. • Undiagnosed diabetes rate ranged from 37% in Los Angeles to 24% in Nashville. • Among the insured type 2 diabetes patients, medication use ranged from 83% to 65%. • Patients with medical claims indicating uncontrolled diabetes ranged from 51% and 36%.
Databáze: OpenAIRE